Akira Ohinata

Phosphodiesterase inhibitors. Part 5: Hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration

Koji Ochiai, Satoshi Takita, Akihiko Kojima et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

Asthma, Antifibrotic Therapy, Inflammatory Lung Disease +11

Phosphodiesterase inhibitors. Part 6: Design, synthesis, and structure–activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity

Akihiko Kojima, Satoshi Takita, Tatsunobu Sumiya et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 30 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +8

Phosphodiesterase inhibitors. Part 2: Design, synthesis, and structure–activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity

Koji Ochiai, N Ando, Kazuhiko Iwase et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 30 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +12

Phosphodiesterase inhibitors. Part 4: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones

Koji Ochiai, Satoshi Takita, Akihiko Kojima et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 29 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +9

Studies on Wittig rearrangement of furfuryl ethers in steroidal side chain synthesis

Masayoshi Tsubuki, Akira Ohinata, Tomoaki Tanaka et al. · Tetrahedron · 2004 · 11 citations

Engineering, Biochemistry, Wittig Rearrangement +7